ARCHIVES

James Doroshow Named NCI Deputy Director, Clinical Research

This article is from The Cancer Letter archive.

Vol. 37 No. 23 | June 10, 2011

Download PDF Visit The Full Archive

Related Articles

Prevention Trial Could Stand On Its Own

October 28, 1994

Letrozole cuts risk of recurrent breast cancer in post-menopausal women.

October 17, 2003

DeVita: It Was Time To Go, and The Action Is Hot At Memorial: Says He’ll Work Well With Paul Marks

August 19, 1988

In Brief: Six On NCA Serve Out Terms, No Successors in Sights DCBD Renamed With ‘Centers’ In Title

February 9, 1990

New Treatment Approaches Valuable For Cancer Pain, Quality Of Life

September 27, 2002

In Brief: Baque Heads Cancer Control Science Programs; Joftes, Davignon T Retire; Schepartz Returns

September 29, 1989